dr. ferris on checkmate-141 trial in head and neck cancer
Published 8 years ago • 747 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
1:15
dr. ferris on significance of checkmate-141 trial for head and neck cancer
-
2:01
dr. ferris on the updated data from checkmate-141 in head and neck cancer
-
1:36
dr. ferris on potential of nivolumab in head and neck cancer
-
2:01
dr. ferris on the checkmate-041 trial for head and neck cancer
-
1:20
dr. ferris on combining immunotherapy and radiation therapy in head and neck cancer
-
4:52
surviving head and neck cancer thanks to research
-
8:15
low-dose nivolumab leads to improved overall survival for head and neck cancer patients
-
3:14
treatments for head and neck cancer (squamous carcinoma tumor)
-
1:09
dr. ferris on immunotherapy in locally advanced head and neck cancer
-
0:54
dr. ferris on the safety profile for rtog 3504 for head and neck cancer
-
1:58
dr. vokes on nivolumab, pembrolizumab approvals in head and neck cancer
-
6:51
pembrolizumab and nivolumab in recurrent hnscc
-
2:13
nivolumab in hnscc
-
0:53
dr. weiss discusses current clinical trials in head and neck cancer
-
1:06
dr. cohen discusses the keynote-040 trial in head and neck cancer
-
0:40
dr. vokes on selecting nivolumab or pembrolizumab for head and neck cancer treatment
-
0:39
barbara burtness, md on whether the checkmate-141 study will accelerate the use of pd-l1 testing
-
11:57
immunotherapy in hnscc
-
4:24
historic perspective on recurrent hnscc
-
6:19
nivolumab-related efficacy and toxicity in hnscc patients